MA56043A - Dérivés hétérocycliques fusionnés - Google Patents
Dérivés hétérocycliques fusionnésInfo
- Publication number
- MA56043A MA56043A MA056043A MA56043A MA56043A MA 56043 A MA56043 A MA 56043A MA 056043 A MA056043 A MA 056043A MA 56043 A MA56043 A MA 56043A MA 56043 A MA56043 A MA 56043A
- Authority
- MA
- Morocco
- Prior art keywords
- fused heterocyclic
- heterocyclic derivatives
- derivatives
- fused
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853533P | 2019-05-28 | 2019-05-28 | |
| EP19176933 | 2019-05-28 | ||
| CN2020085720 | 2020-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56043A true MA56043A (fr) | 2022-04-06 |
Family
ID=71741889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056043A MA56043A (fr) | 2019-05-28 | 2020-05-27 | Dérivés hétérocycliques fusionnés |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP3976617A1 (fr) |
| JP (1) | JP2022535734A (fr) |
| KR (1) | KR20220012913A (fr) |
| CN (1) | CN113906028A (fr) |
| AU (1) | AU2020285718A1 (fr) |
| BR (1) | BR112021022889A8 (fr) |
| CA (1) | CA3138168A1 (fr) |
| CL (1) | CL2021003155A1 (fr) |
| CO (1) | CO2021016433A2 (fr) |
| CR (1) | CR20210666A (fr) |
| IL (1) | IL288322A (fr) |
| JO (1) | JOP20210313A1 (fr) |
| MA (1) | MA56043A (fr) |
| MX (1) | MX2021014575A (fr) |
| PE (1) | PE20220767A1 (fr) |
| SG (1) | SG11202113167QA (fr) |
| WO (1) | WO2020243135A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022116999A1 (fr) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Dérivés hétérocycliques fusionnés et leur utilisation dans le traitement d'une infection par le vhb |
| CN116744927A (zh) * | 2020-12-02 | 2023-09-12 | 杨森科学爱尔兰无限公司 | 稠合杂环衍生物及其在治疗hbv感染中的用途 |
| WO2022116998A1 (fr) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Dérivés hétérocycliques fusionnés utilisés en tant qu'inhibiteurs du vhb |
| AR126048A1 (es) * | 2021-06-02 | 2023-09-06 | Janssen Sciences Ireland Unlimited Co | Derivados heterocíclicos condensados |
| UY39794A (es) | 2021-06-02 | 2022-11-30 | Janssen Sciences Ireland Unlimited Co | Derivados heterocíclicos condensados |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2993174A1 (fr) * | 2014-09-08 | 2016-03-09 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Dérivés de pyrazolopyridine et leur utilisation en thérapie |
| WO2016109684A2 (fr) * | 2014-12-30 | 2016-07-07 | Novira Therapeutics, Inc. | Dérivés et méthodes de traitement d'infections provoquées par le virus de l'hépatite b |
| CN109641896B (zh) * | 2016-06-29 | 2021-09-21 | 诺维拉治疗公司 | 二氮杂酮衍生物及其在治疗乙型肝炎感染中的用途 |
| CN109843892B (zh) * | 2016-06-29 | 2022-01-25 | 诺维拉治疗公司 | 噁二氮杂卓酮衍生物及其在治疗乙型肝炎感染中的用途 |
-
2020
- 2020-05-27 MX MX2021014575A patent/MX2021014575A/es unknown
- 2020-05-27 WO PCT/US2020/034643 patent/WO2020243135A1/fr active Application Filing
- 2020-05-27 SG SG11202113167QA patent/SG11202113167QA/en unknown
- 2020-05-27 JO JOP/2021/0313A patent/JOP20210313A1/ar unknown
- 2020-05-27 CR CR20210666A patent/CR20210666A/es unknown
- 2020-05-27 EP EP20744199.9A patent/EP3976617A1/fr active Pending
- 2020-05-27 PE PE2021001959A patent/PE20220767A1/es unknown
- 2020-05-27 CA CA3138168A patent/CA3138168A1/fr active Pending
- 2020-05-27 KR KR1020217042210A patent/KR20220012913A/ko active Search and Examination
- 2020-05-27 MA MA056043A patent/MA56043A/fr unknown
- 2020-05-27 BR BR112021022889A patent/BR112021022889A8/pt unknown
- 2020-05-27 CN CN202080039617.8A patent/CN113906028A/zh active Pending
- 2020-05-27 JP JP2021570274A patent/JP2022535734A/ja active Pending
- 2020-05-27 AU AU2020285718A patent/AU2020285718A1/en active Pending
-
2021
- 2021-11-23 IL IL288322A patent/IL288322A/en unknown
- 2021-11-26 CL CL2021003155A patent/CL2021003155A1/es unknown
- 2021-12-01 CO CONC2021/0016433A patent/CO2021016433A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JOP20210313A1 (ar) | 2023-01-30 |
| JP2022535734A (ja) | 2022-08-10 |
| CA3138168A1 (fr) | 2020-12-03 |
| KR20220012913A (ko) | 2022-02-04 |
| IL288322A (en) | 2022-01-01 |
| EP3976617A1 (fr) | 2022-04-06 |
| PE20220767A1 (es) | 2022-05-16 |
| BR112021022889A2 (pt) | 2022-01-04 |
| CN113906028A (zh) | 2022-01-07 |
| CR20210666A (es) | 2022-03-11 |
| AU2020285718A1 (en) | 2022-02-03 |
| BR112021022889A8 (pt) | 2024-03-05 |
| MX2021014575A (es) | 2022-05-24 |
| CL2021003155A1 (es) | 2022-07-22 |
| WO2020243135A1 (fr) | 2020-12-03 |
| CO2021016433A2 (es) | 2021-12-10 |
| SG11202113167QA (en) | 2021-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA56043A (fr) | Dérivés hétérocycliques fusionnés | |
| MA55131A (fr) | Nouveaux composés hétérocycliques | |
| DK3436444T3 (da) | Heterocyklisk forbindelse | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK3687999T3 (da) | Rapamycinderivater | |
| MA52623A (fr) | Dérivés de dihydropyrazolo pyrazine carboxamide substitués | |
| DK3887360T3 (da) | Mikrobiocide thiazolderivater | |
| MA54521A (fr) | Dérivés d'oxopyridine substitués | |
| DK3768669T3 (da) | Piperazinazaspiroderivater | |
| MA49127A (fr) | Dérivés d'indole n-substitués | |
| DK3790874T3 (da) | Anthelmintiske kinolinderivater | |
| DK3823970T3 (da) | Yderligere substituerede triazoloquinoxalinderivater | |
| DK3548466T3 (da) | Fremgangsmåde til fremstilling af et mellemprodukt af pesticidaktive heterocykliske derivater med svovlindeholdende substituenter | |
| DK3823971T3 (da) | Substituerede triazol-quinoxalin-derivater | |
| AR120804A1 (es) | Derivados de isoxazolina | |
| ZA202106024B (en) | Heterocyclic derivatives | |
| DE102020112518B8 (de) | Toner | |
| DK3796975T3 (da) | Sulfonylaminobenzamidderivater | |
| DK3870234T3 (da) | Antistoflægemiddelkonjugater omfattende ecteinascidinderivater | |
| DK3645513T3 (da) | Benzazepinderivater | |
| MA53886A (fr) | Pantalon anti-accélération | |
| MA52297A (fr) | Composé hétérocyclique | |
| DK3642202T3 (da) | Dihydro-pyrrolo-pyridin-derivater | |
| DK3472149T3 (da) | Heterocykliske prolinamidderivater | |
| MA56504A (fr) | Dérivés de pyridin-3-yle |